Par Drugs and Chemicals Ltd

NSE:PARHealthcare

₹105.72−3.48%At closeAt close · Mon 19 Oct · ≈ AED 4.08 · Market cap $13.69M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	37.5%	32.6%	30.2%	63.8%	62.2%	48.7%	—	—
Operating margin	22.0%	17.0%	15.3%	57.7%	15.9%	13.0%	13.0%	+0.0 pts
Net margin	19.4%	12.3%	11.9%	15.2%	13.2%	12.6%	12.6%	+0.0 pts
EBITDA margin	30.4%	21.9%	19.4%	24.0%	19.3%	20.4%	—	—
Return on equity	22.2%	15.4%	15.9%	16.9%	13.5%	11.7%	11.7%	+0.0 pts
Return on assets	15.2%	11.7%	12.8%	14.3%	11.2%	10.1%	10.1%	+0.0 pts
Return on capital employed	21.8%	19.8%	19.4%	61.9%	15.6%	11.6%	—	—
Debt / equity	0.2×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—
Debt / assets	10.9%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—
Interest coverage	20.5×	27.9×	109.3×	515.0×	195.2×	105.5×	—	—
Current ratio	2.6×	2.9×	3.5×	4.8×	3.3×	4.7×	4.7×	+0.0%
Quick ratio	2.3×	2.6×	3.1×	4.4×	2.9×	4.3×	—	—
Cash ratio	1.3×	1.1×	1.6×	2.9×	1.7×	3.0×	3.0×	+0.0%
Asset turnover	0.8×	0.9×	1.1×	0.9×	0.8×	0.8×	—	—
Inventory turnover	9.6×	9.1×	11.1×	7.8×	6.2×	9.9×	—	—
Receivables turnover	4.7×	4.0×	5.6×	6.9×	6.0×	8.5×	—	—
Dividend payout	6.6%	16.7%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.